Queen Mary research forecasting the evolution of cancer

May 30, 2018

Researchers from Queen Mary University of London have developed a computer model that forecasts the changes that occur within tumours as they develop.

The research, published in the journal Nature Genetics, in the future aims to enable the prediction of the trajectory of tumour growth in patients, allowing clinicians to pre-empt disease course and tailor treatment regimens accordingly.

The model was developed in collaboration with researchers from Barts Cancer Institute's Centre for Tumour Biology, led by Professor Trevor Graham, the Institute of Cancer research, led by Dr Andrea Sottoriva, and University College London, led by Dr Chris Barnes.

Professor Graham from Queen Mary's Barts Cancer Institute said: "Forecasting of the future offers a real opportunity for clinical benefit that is based on anticipatory action.

"It would be a great advantage to know if a tumour is going to change in a certain way and so be able to administer the most effective treatment in light of the prediction. This work is in its infancy, and the possibilities that this research may have as it matures are very exciting."

Reading the 'secret diary' of a tumour

As tumours grow and become more advanced, different mutations - changes to the genetic code - occur in different cancer cells. Some of these changes may confer an advantage for the cell, making it more suited to survive in its environment. Following the principles of Darwin's theory of Evolution, such cells will be favoured and able to replicate, creating more cells with the same mutation. In this way, different populations of cells with different mutations build up, creating tumours that are highly genetically diverse.

Although it is known that such changes take place as cancer develops, knowing exactly what changes occur and when has proven difficult as tumour samples are often only analysed in the laboratory after they are large enough to be detected in a patient. Therefore, the history of how tumours grow has remained invisible to researchers. The present study, majoritively funded by The Wellcome Trust, endeavoured to fill in this missing history.

By interpreting the genetic sequences of tumour cells, the computer system is able to read the 'secret diary' of mutations hidden in the genome, learning how the cancer has changed over time. Notably, the study revealed that mutations acquired by cells that drive the progression of cancer - known as driver mutations - allow the cells to grow up to 30 per cent faster in some cases than cells without the mutation.

Using a tumour's history to predict its future

The computer system used this genetic information with defined algorithms to predict future changes that may occur as the cancer continues to evolve.

How a cancer changes over time underlies a patient's prognosis, as such changes may determine response to treatment. This study, also supported by Cancer Research UK, makes steps towards the 'mechanistic forecasting' of future disease course and offers great potential for personalised medicine.

Before this research can become a clinical reality, the team first need to verify that the predictions of the system are correct by testing it in pre-clinical models and analysing tumour samples of patients that are under long-term surveillance.

Mr Marc Williams, first author of the paper, added: "We are measuring changes that occur in cancer that have proven difficult to quantify. Such changes may be important in the evolutionary dynamics of individual cancers. Hopefully with these kinds of measurements we will be able to make important predictions of what the future evolutionary trajectory of cancer could be. This is the long-term aim."

Queen Mary University of London

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.